Projekt

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Ac-cess

Laufend - Rekrutierung – laufend · 2022 bis 2027

Art
Klinische Forschung
Reichweite
Multizentrisch, KSSG als teilnehmendes Zentrum
Bereiche
Status
Laufend - Rekrutierung – laufend
Start
2022
Ende
2027
Finanzierungsart
Andere
Label
Anderer Krebs
Kurzbeschreibung/Zielsetzung

SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.